Thermo Fisher Scientific has acquired Fermentas International. With Fermentas’ broad range of molecular and cellular biology research tools, including reagents, enzymes and kits, Thermo Fisher can offer a complete workflow for genomics research while building on its platform of PCR and qPCR tools and resources.

Fermentas, headquartered in Burlington, Ontario, has approximately 500 employees with principal operations in Vilnius, Lithuania.

Thermo Scientific and Fisher Scientific offer a combination of technology development and purchasing options. The products and services are said to help accelerate the pace of scientific discovery, and solve analytical challenges ranging from complex research to routine testing to field applications.

With revenues of more than $10bn, Thermo Fisher Scientific serves customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries.